Skip to main content
. 2016 Sep 29;7(9):e2377. doi: 10.1038/cddis.2016.282

Figure 4.

Figure 4

Sp1 suppresses the stemness of HCC in vitro. (a) Western blot analysis to evaluate the expression levels of Sp1 in HepG2, HCCLM3 wild-type (WT), negative control (NC) and Sp1 knockdown (shRNA1, shRNA 2, shRNA 3, shRNA4) cells. (b and c) Representative images and statistical results of HepG2 and HCCLM3 tumor spheres (>50 μm) after indicated treatments (n=3; scale bar: 50 μm). (d) Western blot analysis of Nanog, EpCAM, CD133 in HepG2, HCCLM3 wild-type (WT), negative control (NC) and Sp1 knockdown (shRNA4) cells. Statistical analysis by paired t-test (*P<0.05, **P<0.01)